✦ LIBER ✦

ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity

✍ Scribed by C.E. WHITTLES; T.M. POCOCK; S.R. WEDGE; J. KENDREW; L.F. HENNEQUIN; S.J. HARPER; D.O. BATES

Book ID: 110058652
Publisher: Informa plc
Year: 2002
Tongue: English
Weight: 253 KB
Volume: 9
Category: Article
ISSN: 1073-9688
DOI: 10.1038/sj.mn.7800164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The fms-like tyrosine kinase, a receptor

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

✍ De Vries, Carlie (author);Escobedo, Jaime A. (author);Ueno, Hikaru (author);Houc 📂 Article 📅 1992 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 840 KB

The fms-like tyrosine kinase, a receptor

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

✍ De Vries, Carlie (author);Escobedo, Jaime A. (author);Ueno, Hikaru (author);Houc 📂 Article 📅 1992 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 840 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Angiogenesis is an important process in cell development, especially in cancer. Vascular endothelial growth factor (VEGF) signaling is an important regulator of angiogenesis. Several therapies that act against VEGF signal transduction have been developed, including YN968D1, which is a potent inhibit

A highly selective, orally bioavailable,

A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo

✍ Kenneth R. LaMontagne; Jeannene Butler; Virna B. Borowski; Angel R. Fuentes-Pesq 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 432 KB

Inhibition of choroidal neovascularizati

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase

✍ Junko Kami; Kimimasa Muranaka; Yasuo Yanagi; Ryo Obata; Yasuhiro Tamaki; Masabum 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 279 KB